Atrial fibrillation and other clinical manifestations of altered TBX5 dosage in typical holt-oram syndrome

Circulation Research

Volumn 103, Issue 7, 2008, Pages

  McDermott, Deborah A ^a   Hatcher, Cathy J ^a   Basson, Craig T ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR TBX5; DNA; HOMEODOMAIN PROTEIN; NKX2 5 PROTEIN, HUMAN; NKX2-5 PROTEIN, HUMAN; T BOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR;

ATRIOVENTRICULAR BLOCK; CLINICAL FEATURE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; GENE DUPLICATION; HEART ATRIUM FIBRILLATION; HOLT ORAM SYNDROME; HUMAN; LETTER; MISSENSE MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; ADOLESCENT; ADULT; ANIMAL; BINDING COMPETITION; CELL CULTURE; CHEMISTRY; CHILD; FEMALE; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETIC LINKAGE; GENETIC SCREENING; GENETICS; MALE; METABOLISM; MOUSE; MULTIPLE MALFORMATION SYNDROME; MUTATION; NOTE; ONSET AGE; PEDIGREE; PROTEIN TRANSPORT; RAT; SYNDROME; TWO HYBRID SYSTEM;

ABNORMALITIES, MULTIPLE; ADOLESCENT; ADULT; AGE OF ONSET; ANIMALS; ATRIAL FIBRILLATION; BINDING, COMPETITIVE; CELLS, CULTURED; CHILD; DNA; ELECTROCARDIOGRAPHY; FEMALE; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC SCREENING; HOMEODOMAIN PROTEINS; HUMANS; LINKAGE (GENETICS); MALE; MICE; MUTATION; PEDIGREE; PHENOTYPE; PROTEIN TRANSPORT; RATS; SYNDROME; T-BOX DOMAIN PROTEINS; TRANSCRIPTION FACTORS; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 54449099368     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.108.181834     Document Type: Letter

References (10)

1. Postma AV, van de Meerakker JBA, Mathijssen IB, Barnett P, Christoffels VM, Ilgun A, Lam J, Wilde AAM, Deprez RHL, Moorman AFM. A Gain-of-function TBX5 mutation is associated with atypical Holt-Oram syndrome and paroxysmal atrial fibrillation. Circ Res. 2008;102:1433-1442.
2. Vaughan CJ, Basson CT. Molecular determinants of atrial and ventricular septal defects and patent ductus arteriosus. Am J Med Genet. 2001;97:304-308.
3. Hatcher CJ, Kim MS, Mah CS, Goldstein MM, Wong B, Mikawa T, Basson CT. TBX5 transcription factor regulates cell proliferation during cardiogenesis. Dev Biol. 2001;230:177-188.
4. Hatcher CJ, Diman NY, Kim MS, Pennisi D, Song Y, Goldstein MM, Mikawa T, Basson CT. A role for Tbx5 in proepicardial cell migration in cardiogenesis. Physiol Genomics. 2004;18:129-140.
5. Liberatore CM, Searcy-Schrick RD, Yutzey KE. Ventricular expression of tbx5 inhibits normal heart chamber development. Dev Biol. 2000;223:169-180.
6. Mori AD, Zhu Y, Vahora I, Nieman B, Koshiba-Takeuchi K, Davidson L, Pizard A, Seidman JG, Seidman CE, Chen XJ, Henkleman RM, Bruneau BG. Tbx5-dependent rheostatic control of cardiac gene expression and morphogenesis. Dev Biol. 2006;297:566-586.
7. Basson CT, Cowley GS, Solomon S, Weissman B, Poznanski AK, Traill TA, Seidman JG, Seidman CE. The clinical and genetic spectrum of Holt-Oram syndrome. N Engl J Med. 1994;330:885-891.
8. Basson CT, Huang T, Lin RC, Bachinsky DR, Weremowicz S, Vaglio A, Bruzzone R, Quadrelli R, Lerone M, Romeo G, Silengo M, Periera A, Krieger J, Mesquita SF, Kamisago M, Morton CC, Pierpont MEM, Muller CW, Seidman JG, Seidman CE. Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutations. Proc Natl Acad Sci U S A. 1999;96:2919-2924.
9. McDermott DA, Bressan MA, Je J, Lee JS, Aftimos S, Brueckner M, Gilbert F, Graham GE, Hannibal MC, Innis JW, Pierpont ME, Raas-Rothschild A, Shanske AL, Smith WE, Spencer RH, St. John-Sutton MG, van Maldergem L, Waggoner DJ, Weber M, Basson CT. TBX5 genetic testing validates strict clinical criteria for Holt-Oram syndrome. Ped Res. 2005;58:981-986.
10. McDermott DA, Basson CT. Holt-Oram syndrome. (Updated November 22, 2006). In: GeneReviews at GeneTests: Medical Genetics Information Resource (database online). Seattle, Wash: University of Washington; 1997-2008. Available at.